Admin
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Admin | Published : November 23, 2013 8:56 PM IST
A diagnostics test for human papilloma virus (HPV) can reduce by a third the incidence of cervical cancer in women worldwide, an expert said at a seminar held at New Delhi.
According to Zoya Brar, co-founder and managing director of Core Diagnostics, a high-end clinical laboratory, cervical cancer is the most frequent cancer among Indian women. There are approximately 132,000 cases of cervical cancer diagnosed annually in India.
'More women in India die from cervical cancer than in any other country,' Brar said at the first Indian Cancer Congress (ICC) that concludes Sunday at Kempinski Ambience Hotel in New Delhi. 'The deaths from this preventable disease will rise unless awareness in women increases and elevates the need for a more robust screening paradigm for cervical cancer,' added Brar whose laboratory is focused on advanced testing techniques and expertise in cardiology, oncology, reproductive disorders, and endocrinology. Brar said she was alarmed at the level of ignorance about cervical cancer during her interactions at a camp organised by Core Diagnostics in Punjab in September.
'Almost one third of cervical cancer can be prevented if HPV testing is used as primary screening test instead of the cytology test.' According to data available at the conference, every third oral cancer patient in the world is from India. While in males, cancers of the oral cavity and lung are the most common causes of cancer incidence and death, in females cervical and breast cancer are the main causes of cancer related illnesses and death.
Experts like Brar said while the government has become proactive, a cervical screening programme was initiated by the Indian Council for Medical Research (ICMR) across various cities in the country. The motive was to prevent cases of cervical cancer by detecting and treating abnormal changes in the cells of the cervix, which can be the precursors of
cancer.
The four-day sponsored by Core Diagnostics is being hosted by the Association of Radio Oncologists of India (AROI), the Indian Association of Surgical Oncology (IASO), the Indian Society of Medical and Pediatric Oncology (ISMPO), the Indian Society of Oncology (ISO), and the Oncology Forum. Over 250 expert speakers and some 5,000 delegates are attending the conference which is expected to act as a catalyst for further research, treatment and dissemination of knowledge in the field of cancer.
What is cervical cancer?
Cervical cancer kills over 33,000 Indian women every year. We singly account for 27% of the world's deaths due to cervical cancer. Because of the dormant nature of the human papillomavirus and our society's norm not to talk about it thousands of women get infected without even knowing they could. Here are some of thetreatment options for cervical cancer:
Precancerous changes in the cervix may be treated with cryosurgery, laser surgery. These methods, howeverare not used to treat invasive cancer. Cryosurgery is a method in which a metal probe is cooled with liquid nitrogen and placed directly on the cervix. This freezes the abnormal cells and thus kills them. Laser surgery involved vapourising abnormal cells with a focused laser beam, directed through the vagina. This method is also used to remove a small piece of tissue for study.
The treatment options for women with cervical cancer are surgery, radiation therapy, chemotherapy or a combination of two or more of these methods. The choice of treatment depends mainly on how big your lesion is, whether your cancer has spread and whether you would like to become pregnant someday.
With inputs from: IANS
